Insight Molecular Diagnostics Inc. Liabilities Assumed
Insight Molecular Diagnostics Inc. (IMDX) reported Liabilities Assumed of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. liabilities assumed for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Insight Molecular Diagnostics Inc. liabilities assumed for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Insight Molecular Diagnostics Inc. liabilities assumed for the quarter ending 2025-12-31 was $765.00K.
- Insight Molecular Diagnostics Inc. liabilities assumed for the quarter ending 2025-09-30 was $99.00K, a 81.63% decline year-over-year.
- Insight Molecular Diagnostics Inc. liabilities assumed for fiscal 2025 was $1.14M, a 36.57% decline from fiscal 2024.
- Insight Molecular Diagnostics Inc. liabilities assumed for fiscal 2024 was $1.79M.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 6 month | Liabilities Assumed 6 month as first filed | Liabilities Assumed 9 month | Liabilities Assumed 9 month as first filed | Liabilities Assumed 12 month | Liabilities Assumed 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 | $765.00K derived: sum of 3 quarters · filed 2026-08-10 | $864.00K derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 | $765.00K derived: sum of 2 quarters · filed 2026-05-13 | $864.00K derived: sum of 3 quarters · filed 2026-05-13 | $1.05M derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-12-31 | $765.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $864.00K derived: sum of 2 quarters · filed 2026-03-26 | $1.05M derived: sum of 3 quarters · filed 2026-08-10 | $1.14M 10-K · filed 2026-03-26 | |||
| 2025-09-30 | $99.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $284.00K derived: sum of 2 quarters · filed 2026-08-10 | $373.00K 10-Q · filed 2025-11-10 | $373.00K derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-06-30 | $185.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $274.00K 10-Q · filed 2026-08-10 | $274.00K derived: sum of 3 quarters · filed 2026-08-10 | $813.00K derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-03-31 | $89.00K 10-Q · filed 2026-05-13 | $89.00K derived: sum of 2 quarters · filed 2026-05-13 | $628.00K derived: sum of 3 quarters · filed 2026-05-13 | $1.13M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $539.00K derived: sum of 2 quarters · filed 2026-03-26 | $1.04M derived: sum of 3 quarters · filed 2026-03-26 | $1.79M 10-K · filed 2026-03-26 | $1.20M 10-K · filed 2025-03-24 | ||
| 2024-09-30 | $539.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.04M derived: sum of 2 quarters · filed 2025-11-10 | $1.79M 10-Q · filed 2025-11-10 | $1.20M 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | $504.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $1.25M 10-Q · filed 2025-08-11 | $491.00K 10-Q · filed 2024-08-08 | ||||
| 2024-03-31 | $751.00K 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |